Jump Financial’s Dr. Reddy's Laboratories RDY Stock Holding History

Jump Financial’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.51M	Buy	104,200 +12,783	+14%	+$172K	0.01%	1007
2026 Q1	$1.27M	Sell	91,417 -71,539	-44%	-$996K	0.02%	831
2025 Q4	$2.29M	Buy	162,956 +22,656	+16%	+$318K	0.03%	620
2025 Q3	$1.96M	Sell	140,300 -93,500	-40%	-$1.35M	0.02%	744
2025 Q2	$3.51M	Buy	233,800 +86,689	+59%	+$1.24M	0.04%	534
2025 Q1	$1.94M	Buy	147,111 +123,911	+534%	+$1.71M	0.03%	588
2024 Q4	$366K	Buy	23,200 +9,995	+76%	+$150K	0.01%	1226
2024 Q3	$210K	Buy	+13,205	New	+$212K	﹤0.01%	1452
2023 Q4	–	Sell	-87,650	Closed	-$1.17M	–	2165
2023 Q3	$1.17M	Sell	87,650 -59,850	-41%	-$810K	0.04%	598
2023 Q2	$1.86M	Sell	147,500 -18,920	-11%	-$221K	0.07%	418
2023 Q1	$1.89M	Buy	+166,420	New	+$1.8M	0.08%	377
2022 Q4	–	Sell	-62,200	Closed	-$651K	–	1956
2022 Q3	$651K	Buy	+62,200	New	+$662K	0.03%	782

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Jump Financial's RDY Position: Q2 2026 in Review

Jump Financial increased its Dr. Reddy's Laboratories (RDY) stake by 14% in Q2 2026, buying an estimated $172K and bringing the position to 104,200 shares worth $1.51M. The position accounts for 0.01% of the portfolio, ranked #1007.

Jump Financial first reported a position in RDY in Q3 2022 and has held it in 12 quarters since. The position peaked at $3.51M in Q2 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Jump Financial held 104,200 shares of Dr. Reddy's Laboratories worth $1.51M as of Q2 2026.
Jump Financial bought 12,783 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $172K.
Dr. Reddy's Laboratories made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1007 holding.
Jump Financial first reported a position in Dr. Reddy's Laboratories in Q3 2022 and has held it in 12 quarters since.
Jump Financial's Dr. Reddy's Laboratories position peaked at $3.51M in Q2 2025.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.